Skip to main content
رجوع
Watch Compare

Tenon Medical, Inc.

جودة البيانات: 100%
مُدرج أيضًا باسم TNONW NASDAQ
TNON
NASDAQ Manufacturing Measuring & Analyzing Instruments
KWD 0.81
▼ KWD 0.01 (-1.34%)
6 months return
—
Momentum
Neutral
ROE
-218.16%

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)20.35%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-218.16%
أقل من متوسط القطاع (-54.68%)
ROIC-127.31%
Net Margin-318.36%
Op. Margin-324.34%

الأمان

Debt / Equity
N/A
Current Ratio2.15
Interest Coverage-376.24

التقييم

PE (TTM|NTM)
-0.66 | -1.23
أعلى من متوسط القطاع (-1.49)
P/B Ratio1.72
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -11.02 M
Capital efficient — spends only 6.92% of revenue on capex

Price History

الاتجاهات المالية

السعر المستهدف للمحللين

2 محللين
Strong Buy
+239.9%
upside to target
الحالي
KWD 0.81
Consensus Target
KWD 2.75
KWD 2.50
أدنى
KWD 3.00
أعلى
التوقعات
مكرر الربحية المستقبلي
-1.23
ربحية السهم المستقبلية
-KWD 0.63
الإيرادات المقدّرة
9.66 M

مفاجآت الأرباح

EPS
Reported Estimate Forecast
Next: Q1 2026 · EPS Est: -KWD 0.31 · Rev Est: 1.30 M
Q12025 Q22025 Q32025 Q42025 Q1 '26 Q2 '26
Reported -KWD 1.01 -KWD 0.36 -KWD 0.40 -KWD 0.22 — —
Estimate -KWD 0.92 -KWD 0.47 -KWD 0.37 -KWD 0.36 -KWD 0.31 -KWD 0.25
المفاجأة -9.78% +23.40% -8.11% +38.89% — —

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) 20.35% Revenue Growth (3Y) 16.06%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -218.16% · Net Margin: -318.36%
Revenue (TTM) 3.94 M Net Income (TTM) -12.56 M
ROE -218.16% ROA -116.91%
Gross Margin 59.79% Operating Margin -324.34%
Net Margin -318.36% Free Cash Flow (TTM) -11.02 M
ROIC -127.31% FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 2.15
Debt / Equity N/A Current Ratio 2.15
Interest Coverage -376.24 Asset Turnover 0.37
Working Capital 3.50 M Tangible Book Value 1.89 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -0.66 · EV/EBITDA: N/A
P/E Ratio -0.66 Forward P/E -1.23
P/B Ratio 1.72 P/S Ratio 2.09
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 0.86 Fwd Earnings Yield N/A
FCF Yield -133.37%
Market Cap 8.26 M Enterprise Value 4.82 M

Per Share

EPS: -1.70 · FCF/Share: -0.98
EPS (Diluted TTM) -1.70 Revenue / Share 0.35
FCF / Share -0.98 OCF / Share -0.95
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 87.75% · CapEx/Rev: 6.92%
CapEx / Revenue 6.92% FCF Conversion 87.75%
SBC-Adj. FCF -13.28 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Revenue 3.94 M 3.28 M 2.93 M 691,000.0
Net Income -12.56 M -13.67 M -15.58 M -18.92 M
EPS (Diluted) -1.70 -11.26 -8.59 -2.36
Gross Profit 2.36 M 1.71 M 1.24 M -641,000.0
Operating Income -12.79 M -13.77 M -15.73 M -18.73 M
EBITDA — — — —
R&D Expenses 2.15 M 2.60 M 3.16 M 2.83 M
SG&A Expenses — — — —
D&A 262,000.0 408,000.0 199,000.0 —
Interest Expense 34,000.0 34,000.0 21,000.0 354,000.0
Income Tax — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Total Assets 10.76 M 9.84 M 6.35 M 11.09 M
Total Liabilities 5.72 M 3.87 M 5.57 M 4.84 M
Shareholders' Equity 5.04 M 5.97 M 778,000.0 6.25 M
Total Debt — — — —
Cash & Equivalents 3.76 M 6.54 M 2.43 M 2.13 M
Current Assets 6.77 M 8.21 M 3.89 M 9.35 M
Current Liabilities 3.21 M 1.87 M 3.14 M 2.53 M

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1605 نظير)
المقياس السهم وسيط القطاع
P/E -0.7 -1.5
P/B 1.7 1.6
ROE % -218.2 -54.7
Net Margin % -318.4 -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3